Krystal Biotech, Inc. (KRYS)

282.01 -9.78 (-3.35%) USD  |  NASDAQ  |  Jan 15, 16:00
282.33 +0.32 (+0.11%) Pre-Market: 20:00
More

Krystal Biotech EBITDA (TTM)

EBITDA (TTM) Chart

View EBITDA (TTM) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (TTM) Range, Past 5 Years

View EBITDA (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (TTM) Benchmarks

View EBITDA (TTM) Benchmarks
Start Trial
DexCom, Inc. Upgrade
BioLife Solutions, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade